Virginia Retirement Systems’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$239K Buy
11,600
+1,200
+12% +$30.4K ﹤0.01% 849
2023
Q2
$307K Sell
10,400
-3,300
-24% -$92.8K ﹤0.01% 834
2023
Q1
$316K Buy
13,700
+1,000
+8% +$27.5K ﹤0.01% 863
2022
Q4
$353K Sell
12,700
-300
-2% -$8.93K ﹤0.01% 921
2022
Q3
$399K Buy
+13,000
New +$423K ﹤0.01% 864
2022
Q1
$470K Sell
14,600
-11,100
-43% -$382K ﹤0.01% 864
2021
Q4
$1.15K Sell
25,700
-2,900
-10% -$137K 0.01% 626
2021
Q3
$1.44M Buy
28,600
+6,400
+29% +$361K 0.01% 504
2021
Q2
$1.74M Buy
22,200
+1,600
+8% +$99K 0.02% 468
2021
Q1
$1.18M Buy
20,600
+14,800
+255% +$991K 0.01% 599
2020
Q4
$486K Sell
5,800
-8,100
-58% -$490K 0.01% 851
2020
Q3
$498K Buy
+13,900
New +$419K 0.01% 772

Other funds holding DNLI